Metabolomics at the cutting edge of risk prediction of MASLD

En Ying Tan, Mark D. Muthiah, Arun J. Sanyal · 2024

Read Metabolomics at the cutting edge of risk prediction of MASLD by En Ying Tan, Mark D. Muthiah, Arun J. Sanyal (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11722125.txt.

Description

En Ying Tan and co-authors survey metabolite marks for fatty liver risk in a 2024 review. Metabolic dysfunction steatohepatitis liver disease is a world scale health threat, and firm blood marks for staging it are lacking. Blood metabolites mirror both body wide strain and liver change.

The review sorts shifts by disease trait: fat plus inflammation, activity grade, and scar stage. Panels built from metabolite sets earn a hard look for real world fit. The authors weigh each panel biology and clinic worth, then flag what proof must come next before wide use. Fit for purpose testing is the ask.

Catalog record

CREATOREn Ying Tan, Mark D. Muthiah, Arun J. Sanyal
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE75 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11722125

Browse the full library · About the Tower of Babel